:::

詳目顯示

回上一頁
題名:美國生物科技新專利適格性原則之研究
書刊名:中正財經法學
作者:李順典
作者(外文):Lee, Shun-tien
出版日期:2020
卷期:21
頁次:頁97-160
主題關鍵詞:生物技術專利適格性削弱創新策略BiotechnologyPatent eligibilityUndermineInnovationStrategies
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:1
期刊論文
1.Lemley, Mark A.、Risch, Michael、Sichelman, Ted、Wagner, R. Polk(2011)。Life after Bilski。Stanford Law Review,63,1315-1346。  new window
2.Merges, Robert P.(1999)。As Many as Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and Patent System Reform。Berkeley Technology Law Journal,14。  new window
3.Risch, Michael(2008)。Everything is Patentable。Tennessee Law Review,75。  new window
4.Allison, John R.、Lemley, Mark A.、Schwartz, David L.(2014)。Understanding the Realities of Modern Patent Litigation。Texas Law Review,92。  new window
5.Eisenberg, Rebecca S.(2012)。Wisdom of the ages or dead-hand control? Patentable subject matter for diagnostic methods after in re Bilski。Case Western Reserve Journal of Law, Technology & the Internet,3,1-65。  new window
6.Rai, Arti Kaur(1999)。Regulating Scientific Research: Intellectual Property Rights and the Norms of Science。Northwestern University Law Review,94(1),77-152。  new window
7.Sanger, Frederick、Niclen, Steve、Coulson, Alan R.(1977)。DNA sequencing with chain-terminating inhibitors。Proceedings of the National Academy of Sciences of the United States of America,74(12),5463-5467。  new window
8.Borson, D. Benjamin(1994)。The Human Genome Projects: Patenting Human Genes and Biotechnology. Is the Human Genome Patentable?。IDEA: The Journal of Law and Technology,35(4)。  new window
9.Heller, Michael A.、Eisenberg, Rebecca S.(1998)。Can Patents Deter Innovation? The Anticommons in Biomedical Research。Science,280(5364),698-701。  new window
10.Rai, Arti K.、Sherkow, Jacob S.(2016)。The Changing Life Science Patent Landscape。Nature Biotechnology,34(3)。  new window
11.Madigan, Kevin、Mossoff, Adam(2017)。Turning Gold Into Lead: How Patent Eligibility Doctrine is Undermining U.S. Leadership in Innovation。George Mason Law Review,24,939-960。  new window
12.Price, W. Nicholson II(2015)。Black-Box Medicine。Harvard Journal of Law & Technology,28(2),419-467。  new window
13.Burk, Dan L.、Lemley, Mark A.(2003)。Policy Levers in Patent Law。Virginia Law Review,89(7),1575-1696。  new window
14.Evans, Barbara J.(2014)。Economic regulation of next-generation sequencing。The Journal of Law, Medicine & Ethics,42,51-66。  new window
15.Leader, Benjamin(2008)。Protein Therapeutics: a Summary and Pharmacological Classification。Nature Reviews Drug Discovery,7(1),21-39。  new window
16.Beauchamp, Christopher(2013)。Patenting Nature: A Problem of History。Stanford Technology Law Review,16,257-311。  new window
17.Adams, Christopher、Brantner, Van V.(2006)。Estimating the Cost of New Drug Development: Is It Really 802 Million?。Health Affairs,25(2),420-428。  new window
18.Yarbrough, Daniel K.(2014)。After Myriad: Reconsidering the Incentives for Innovation in the Biotech Industry。Michigan Telecommunications and Technology Law Review,21。  new window
19.Robinson, Douglas、Medlock, Nina(2005)。Diamond v. Chakrabarty: A Retrospective on 25 Years of Biotech Patents。Intellectual Property and Technology Law Journal,17。  new window
20.Noorani, H. Z.(1996)。Cost Comparison of Molecular Versus Conventional Screening of Relatives at Risk for Retinoblastoma。American Journal of Human Genetics,59。  new window
21.Dolin, Gregory(2013)。Exclusivity Without Patents: The New Frontier of FDA Regulation for Genetic Materials。Iowa Law Review,98。  new window
22.Kane, Eileen M.(2011)。Patenting Genes and Genetic Methods: What's at Stake?。Journal of Business & Technology Law,6。  new window
23.Van Gieson, Edward、Stellman, Paul(2010)。Killing Good Patents to Wipe out Bad Patents: Bilski, the Evolution of Patentable Subject Matter Rules, and the Inability to Save Valuable Patents Using the Reissue Statute。Santa Clara High Technology Law Journal,27。  new window
24.Lefstin, Jeffrey A.、Menell, Peter S.、Taylor, David O.(2018)。Final Report of the Berkeley Center for Law & Technology Section 101 Workshop: Addressing Patent Eligibility Challenges。Berkeley Technology Law Journal,33。  new window
25.Golden, John M.(2001)。Biotechnology, Technology Policy, and Patentability: Natural Products and Invention in the American System。Emory Law Journal,50。  new window
26.Strandburg, Katherine J.(2012)。Much Ado About Preemption。Houston Law Review,50。  new window
27.Carrier, Michael A.(2002)。Unraveling the Patent-Antitrust Paradox。University of Pennsylvania Law Review,150(3)。  new window
28.Sikora, Mike(2018)。Mayo, myriad, and a muddled analysis: Do recent changes to the patentable subject matter doctrine threaten patent protections for epigenetics-based inventions?。Minnesota Law Review,102(5),2229-2268。  new window
29.Sigareva, Marina A.、O'Donnell, Ryan W.(2017)。Global Strategies for Protecting Inventions in the Biotechnology Sector。New Jersey Law Journal,307。  new window
30.Andrews, Lori B.(2002)。Genes and Patent Policy: Rethinking Intellectual Property Rights。George Mason Law Review,3。  new window
31.Tudhope, Nicole(2018)。Misunderstanding Biotechnology: Separating Laws of Nature From Underlying Technological Developments。Willamette Law Review,54。  new window
32.Milunsky, Aubrey(1993)。The New Genetics: From Research to Reality。Suffolk University Law Review,27,1307-1325。  new window
33.Gugliuzza, Paul R.(2019)。The Procedure of Patent Eligibility。Texas Law Review,97。  new window
34.Gugliuzza, Paul R.、Lemley, Mark A.(2018)。Can a Court Change the Law by Saying Nothing?。Vanderbilt Law Review,71。  new window
35.Peace, N.、Christie, A.(1986)。Intellectual Property Protection for the Products of Animal Breeding。European Intellectual Property Review,18(4),213-233。  new window
36.Eisenberg, Rebecca S.(2000)。Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences。Emory Law Journal,49。  new window
37.Feldman, Robin、Price, W. Nicholson II(2014)。Patent Trolling: Why Bio & Pharmaceuticals Are at Risk。Stanford Technology Law Review,2,773-805。  new window
圖書
1.Andrews, Lori B.、Mehlman, Maxwell J.、Rothstein, Mark A.(2010)。Genetics: Ethics, Law And Policy。Thomson Reuters Business Press。  new window
2.Llewelyn, Margaret、Adcock, Mike(2006)。European Plant Intellectual Property。Hart Publishing。  new window
3.Bouchoux, Deborah E.(2009)。Intellectual Property: The Law of Trademarks, Copyrights, Patents, and Trade Secrets。Delmar Publisher。  new window
4.Westerlund, Li(2002)。Biotech Patents: Equivalency and Exclusion under European and US Patent Law。Kluwer Law International Publisher。  new window
5.Merges, Robert Patrick、Duffy, John Fitzgerald(2017)。Patent Law and Policy: Cases AND Materials。Delmar Publisher。  new window
6.Landes, William M.、Posner, Richard A.(2003)。The Economic Structure of Intellectual Property Law。Thomson Reuters Business Press。  new window
單篇論文
1.Mack, Susan J.(2014)。New Political and Regulatory Issues Complicate Protecting Biotechnology Intellectual Property,Aspatore。  new window
其他
1.U.S. Patent & Trademark Office(2017)。Comments of the Pharmaceutical Research and Manufacturers of America,https://www.uspto.gov.sites/default/f51es/documents/RT2%20Comments%20PhRMA.pdf。  new window
2.(20140214)。Ariosa's prenatal test gains crucial New York lab licensing certification,http://www.fiercediagnostics.com/story/ariosas-prenataI-test-gains-crucial-new-york-lab-licensing-certification/2014-02-14。  new window
3.Gold, Ashley。Lee Staying on as Patent Chief Under Trump Administration,http://www.politico.com/blogs/donald-trump-administration/2017/01/michelle-Iee-patent-offlce-chief-to-stay-on-233847。  new window
4.Lee, Christopher(20070528)。Slump in NIH Funding is Taking Toll on Research,http://www.washingtonpost.com/wp-dyn/content/article/2007/05/27/AR2007052700794.html。  new window
5.Tysver, Daniel A.(2019)。Are Software and Business Methods Still Patentable After the Bilski Decision?,http://www.bitlaw.com/software-patent/bilski-and-software-patents.html。  new window
6.Quinn, Gene。SCOTUS Rules Alice Software Claims Patent Ineligible,http://www.ipwatchdog.com/2014/06/19/scotus-rules-alice-software-claims-patent-ineligible。  new window
7.Angier, Natalie(19940920)。Fierce Competition Marked Fervid Race for Cancer Gene,http://www.nytimes.com/1994/09/20/science/fierce-competition-marked-fervid-race-for-cancer-gene.html?pagewanted=all。  new window
8.Foroohar, Rana(20170903)。A Better US Patent System Will Spur Innovation,https://www.ft.com/content/74114a6c-8f28-1Ie7.9084-d0cl7942ba93?mhq5j=e6。  new window
9.Plotkin, Robert。Software Patents are Only as Dead as Schr6dinger's Cat,http://www.ipwatchdog.com/2014/10/06/software-patents-are-only-as>dead-as-schrodingers-cat。  new window
10.Sachs, Robert R.。The One Year Anniversary: The Aftermath of Alice Strom,http://www.bilskiblog.com/blog/2015/06/the-one-year-anniversary-the-aftermath-of-alicestomi.html。  new window
11.Callahan, Steven。Alice: The Death of Software-Related Patents?,http://www.ndtexblog.com/?p=3550。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE